Rajajinagar, India

Bheemashankar A Kulkarni

USPTO Granted Patents = 19 


 

Average Co-Inventor Count = 9.1

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Karnataka State, IN (2016)
  • Pune, IN (2016)
  • Noida, IN (2014 - 2017)
  • Rajajinagar, IN (2015 - 2017)
  • Maharashtra, IN (2019)
  • Bengaluru, IN (2014 - 2021)
  • Mumbia, IN (2022)
  • Mumbai, IN (2021 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: Innovations by Bheemashankar A Kulkarni

Introduction

Bheemashankar A Kulkarni, an esteemed inventor based in Maharashtra, India, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of seven patents, he continues to pave the way for innovative treatments that address various medical conditions.

Latest Patents

Kulkarni's latest patents demonstrate his dedication to advancing medical science. One notable patent focuses on bicyclic compounds, compositions, and their medicinal applications. It describes substituted bicyclic compounds, including their tautomers, polymorphs, and prodrugs. These compounds are particularly useful in treating conditions related to the inhibition of the retinoic acid-related orphan receptor gamma (RORγ), targeting inflammatory and autoimmune disorders such as rheumatoid arthritis, psoriasis, and multiple sclerosis, among others.

Another significant patent involves novel pyridine derivatives. This patent outlines compounds and their pharmaceutically acceptable salts, which are shown to inhibit CYP17 activity. These compounds have potential applications in treating diseases characterized by abnormal cellular proliferation, notably various forms of cancer, including prostate cancer.

Career Highlights

Bheemashankar Kulkarni has had a distinguished career, working with reputable organizations in the biotech and pharmaceutical sectors. He has made substantial contributions during his tenure at Asana Biosciences, LLC and Advinus Therapeutics Private Limited, where he developed innovative compounds that are at the forefront of medical research.

Collaborations

Throughout his career, Kulkarni has collaborated with numerous professionals in the field. He worked alongside Roger Astbury Smith and Nicholas James Laping, both of whom have contributed to various projects and initiatives aimed at advancing medicinal chemistry and therapeutic innovations.

Conclusion

Bheemashankar A Kulkarni's impact on the field of medicinal applications is profound, as evidenced by his multiple patents and collaborations. His work continues to inspire future innovations that have the potential to change the landscape of treatment for various medical conditions. As the pharmaceutical industry evolves, Kulkarni's contributions will remain pivotal in the journey towards developing effective therapies tailored to meet urgent health needs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…